Andhra CRDA proposes projects worth Rs 81,317 cr for Amaravati, invites tenders for Rs 50,552 cr
Chief Minister N Chandrababu Naidu reviewed the progress of Amaravati's construction at the Secretariat, in a meeting attended by Municipal Minister P. Narayana, senior officials, and contractors.
"CRDA has proposed works worth a total of Rs 81,317 crore for the construction of the capital city. Currently, it called tenders for projects worth Rs 50,552 crore," said an official press release. Officials informed the CM that construction work has commenced on 74 projects, covering housing, public buildings, roads, ducts, flood control measures, and other infrastructure.The TDP supremo instructed officials to complete Amaravati construction work six months ahead of the schedule.
He reviewed the progress of infrastructure development in areas under the LPS (land pooling scheme) and the construction of residences for ministers, MLAs, officials, employees, and judges. On returnable plots to farmers, Naidu called for measures which would neither inconvenience the peasants nor impact Amaravati's master plan. Further, the CM instructed officials to expedite approvals to agencies intending to build their offices in the greenfield capital city, especially for institutions like BITS - Pilani, XLRI and others. In addition, he suggested continuous monitoring of progress by 72 organisations which received land in the capital region.The CM noted that mere allocation of land does not complete the capital's development as investments and ventures need to follow. He sought investments across diverse sectors in Amaravati, including Sport City, tourism, airport infrastructure, biotechnology, educational institutions, and hospitals and directed officials to invite India's top 10 real estate companies to take up projects in the region.
Emphasising the vision of transforming Amaravati into a green energy corridor, Naidu called for the promotion of electric vehicles, including monitoring and displaying air quality across seed capital, capital city and capital area regions of Amaravati.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mint
21 minutes ago
- Mint
Vodafone Idea Q1 Results: Net loss at ₹6,608 crore, improves sequentially; ARPU rises to ₹177
Vodafone Idea announced its financial performance for the June-ending quarter today, August 14, post market hours, reporting a net loss of ₹ 6,608 crore, higher than the net loss of ₹ 6,432 crore reported in the same period last year. However, on a sequential basis, losses narrowed compared to the preceding March quarter, when the company reported a net loss of ₹ 7,166 crore. Its consolidated revenue from operations during the quarter stood at ₹ 11,022 crore, a 5% increase from ₹ 10,508 crore in the June 2024 quarter. The average revenue per user (ARPU), a key metric for telecom companies—came in at ₹ 177, above analysts' estimates of ₹ 167, driven by subscriber upgrades and an improved mix. The metric improved by 15% from ₹ 154 in Q1FY25. At the operating level, the company reported an EBITDA of ₹ 4,612 crore, compared to ₹ 4,204 crore in the year-ago quarter, with margins rising to 41.8% from 40%. The company's finance cost jumped to ₹ 5892 in Q1 crore from ₹ 5518 crore, but came in lower as compared to ₹ 6471 crore in the preceding March quarter. As on June 30, 2025, the debt from banks was ₹ 19.3 billion and the cash and bank balance stood at Rs. 68.3 billion. The company said that investments made over the past three quarters to expand its 4G coverage have started yielding results, as reflected in the 90% lower subscriber loss compared to Q2 and Q3 of the last financial year — the lowest decline since the merger. It further stated that it continues to invest in capex, and to support its broader capex plans of ₹ 500–550 billion, it remains engaged with lenders to secure debt financing. On the back of investments in high-speed broadband network coverage and capacity, including the addition of new 4G sites, upgrades to its core and transmission network, and multiple other initiatives, subscriber decline during the quarter was restricted to 0.5 million, around 90% lower than the 5 million decline recorded in Q2 and Q3 of the last financial year. This marked its strongest performance since the merger. The company's total subscriber base stood at 197.7 million. It closed the quarter with 127.4 million 4G/5G subscribers, up from 126.7 million in the same period last year. Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.
Hans India
24 minutes ago
- Hans India
AstraZeneca Pharma India's net profit slips 4 pc in Q1
Mumbai: AstraZeneca Pharma India Limited on Thursday reported a 4.12 per cent decline in net profit for the first quarter (Q1) of FY26, with earnings falling to Rs 55.8 crore from Rs 58.2 crore in the previous quarter (Q4 FY25). This dip came despite a strong rise in revenue from operations, which grew 9.56 per cent sequentially to Rs 526.3 crore from Rs 480.4 crore, according to its stock exchange filing. Other income saw a sharp decline of 30.43 per cent, dropping to Rs 11.2 crore from Rs 16.1 crore in Q4 FY25. However, total income rose 8.23 per cent to Rs 537.5 crore from Rs 496.6 crore, driven by solid operational performance. Total expenses increased by 12.12 per cent to Rs 462.4 crore, compared to Rs 412.4 crore in the previous quarter, the company stated in its regulatory filing. Bhavana Agrawal, Chief Financial Officer and Director of the Company, said the strong quarterly performance reflects the power of science-led innovation combined with disciplined execution. 'Each regulatory milestone brings us closer to transforming outcomes for patients living with chronic diseases. We remain focused on expanding our portfolio, strengthening partnerships, and ensuring that breakthrough medicines reach the people who need them most,' she added. Praveen Rao Akkinepally, Country President and Managing Director, said that delivering consistent growth across therapy areas reaffirms the strength of the company's 'Growth Through Innovation' strategy. 'These results are a testament to what is possible when science and purpose come together,' he noted. AstraZeneca, a global science-led biopharmaceutical company, focuses on the discovery, development, and commercialisation of prescription medicines, primarily in oncology, cardiovascular, renal and metabolism, respiratory, and rare diseases. The company operates in over 100 countries, with its medicines used by millions of patients worldwide. Completing 45 years in India, AstraZeneca Pharma India Limited is headquartered in Bengaluru and employs over 600 people across the country.
&w=3840&q=100)
Business Standard
24 minutes ago
- Business Standard
Cafe Coffee Day Q1FY26 results: Loss shrinks to ₹11 cr, revenue rises 6%
Coffee Day Global, which operates popular caf chain Cafe Coffee Day, has narrowed down its loss to Rs 11 crore, and its net revenue went up 6 per cent to Rs 263 crore in the June quarter of FY26. The company had reported a net revenue of Rs 248 crore, and its loss after tax was at Rs 17 crore in the corresponding April-June period a year ago, according to the regulatory filing by Coffee Day Global's parent entity Coffee Day Enterprises Ltd. Its Average Sales Per Day (ASPD) was marginally down YoY to Rs 20,747, in comparison to Rs 20,772 a year ago. However, it was up 1.31 per cent sequentially from Rs 20,477 recorded in the March quarter. Besides, the total store count of Cafe Coffee Day has gone down to 427 in the June quarter. It was at 448 in the year-ago quarter. Cafe Coffee Day vending machine count has gone up to 55,189 in the June quarter, 1.25 per cent higher against 54,505 in the year-ago June quarter and 54,100 in the preceding March quarter. The parent entity, Coffee Day Enterprises Ltd (CDEL), reported a profit of Rs 23.28 crore in the June quarter of FY26. It had reported a loss of Rs 13.28 crore in the corresponding June quarter of last fiscal. Revenue from operations of CDEL was up 3.55 per cent to Rs 269.32 crore in the June quarter of FY26. Shares of Coffee Day Enterprises Ltd on Thursday settled at Rs 37.86 apiece on BSE, down 0.53 per cent from the previous close.
